Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-51951

Single-particle
2.4 Å
EMD-51951
3D View Gallery
Deposition: 29/10/2024
Map released: 02/04/2025
Last modified: 09/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-51951
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9h93 summary report (pdf.gz) Map and 9h93 FULL report (pdf.gz)
EMICSS annotations (xml)

Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC6b) from a yeast expression system.

EMD-51951

Single-particle
2.4 Å
EMD-51951
3D View Gallery
Deposition: 29/10/2024
Map released: 02/04/2025
Last modified: 09/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Poliovirus 2
Sample: Poliovirus 2
Fitted models: 9h93

Deposition Authors: Bahar MW, Sherry L , Stonehouse NJ, Rowlands DJ, Fry EE, Stuart DI
Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.
Sherry L , Grehan K , Bahar MW, Swanson JJ, Fox H, Matthews S, Carlyle S, Qin L, Porta C, Wilkinson S, Robb S, Clark N, Liddell J, Fry EE, Stuart DI, Macadam AJ, Rowlands DJ, Stonehouse NJ
(2025) NPJ Vaccines , 10 , 64 - 64
PUBMED: 40164627
DOI: doi:10.1038/s41541-025-01111-2
ISSN: 2059-0105
Grant Support: